Palantir Technologies Inc. (PLTR) is expanding its collaboration with PwC to combine its AI capabilities. The company has chosen the U.K. as its European headquarters for AI research and development. Palantir is also reportedly poised to secure a significant contract with the U.K.'s National Health Service (NHS), valued at approximately £480 million ($579 million). However, the financial impact of the NHS contract might not significantly influence Palantir's immediate financial results.